1. Therapeutic nuclear medicine expands to breast cancer

   • Marc André Mahé
   • Albert Lisbona
   • Jean-François Chatal

   Editorial Commentary 05 December 2009 Pages: 201 - 202

2. Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with ⁹⁰Y-labeled biotin

   • Giovanni Paganelli
   • Concetta De Cicco
   • Umberto Veronesi

   Original Article 04 September 2009 Pages: 203 - 211

   

3. Individualized dosimetry in patients undergoing therapy with ¹⁷⁷Lu-DOTA-D-Phe¹-Tyr³-octreotate

   • Mattias Sandström
   • Ulrike Garske
   • Hans Lundqvist

   Original Article 02 September 2009 Pages: 212 - 225

   

4. Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides

   • Erik Vegt
   • Annemarie Eek
   • Otto C. Boerman

   Original Article Open access 01 September 2009 Pages: 226 - 234

   

5. Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model

   • Yong Jin Lee
   • June-Key Chung
   • Myung Chul Lee

   Original Article 01 September 2009 Pages: 235 - 241

   

6. Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium

   • Daniele Barbaro
   • Mariano Grosso
   • Domenico Rubello

   Original Article 04 September 2009 Pages: 242 - 249

   

7. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

   • Lars R. Perk
   • Maria J. W. D. Vosjan
   • Guus A. M. S. van Dongen

   Original Article Open access 18 September 2009 Pages: 250 - 259

   

8. ¹⁸⁶Re-maSGS-Z_HER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumours

   • Anna Orlova
   • Thuy A. Tran
   • Vladimir Tolmachev

   Original Article 22 September 2009 Pages: 260 - 269

   

9. A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer

   • Glenn D. Flux
   • Masud Haq
   • Clive L. Harmer

   Original Article 04 September 2009 Pages: 270 - 275

   

10. No survival difference after successful ¹³¹I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer

    • Frederik Anton Verburg
    • Marcel P. M. Stokkel
    • Markus Luster

    Original Article 29 November 2009 Pages: 276 - 283

    

11. Meta-analysis of the performance of ¹⁸F-FDG PET in cutaneous melanoma

    • Felisa Jiménez-Requena
    • Roberto C. Delgado-Bolton
    • José L. Carreras-Delgado

    Original Article 02 September 2009 Pages: 284 - 300

    

12. Predictive factors of [¹¹C]choline PET/CT in patients with biochemical failure after radical prostatectomy

    • Giampiero Giovacchini
    • Maria Picchio
    • Cristina Messa

    Original Article 15 September 2009 Pages: 301 - 309

    

13. Potential impact of ⁶⁸Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas

    • Fonyuy Nyuyki
    • Michail Plotkin
    • Reinhard Wurm

    Original Article 18 September 2009 Pages: 310 - 318

    

14. Role of PET/CT in malignant pediatric lymphoma

    • Raef Riad
    • Walid Omar
    • Hussein Abdel-Dayem

    Original Article 15 September 2009 Pages: 319 - 329

    

15. Radiobiological effects of hypoxia-dependent uptake of ⁶⁴Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells

    • Amanda J. Weeks
    • Rowena L. Paul
    • Daniel R. Lloyd

    Original Article 14 November 2009 Pages: 330 - 338

    

16. Detection of hypoxia in microscopic tumors using ¹³¹I-labeled iodo-azomycin galactopyranoside (¹³¹I-IAZGP) digital autoradiography

    • Xiao-Feng Li
    • Xiaorong Sun
    • Joseph A. O’Donoghue

    Original Article 17 November 2009 Pages: 339 - 348

    

17. Assessment of poststress left ventricular ejection fraction by gated SPECT: comparison with equilibrium radionuclide angiocardiography

    • Wanda Acampa
    • Maria Grazia Caprio
    • Alberto Cuocolo

    Original Article 01 December 2009 Pages: 349 - 356

    

18. Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes

    • Cecilia Marini
    • GianPaolo Bezante
    • Gianmario Sambuceti

    Original Article 03 December 2009 Pages: 357 - 367

    

19. Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia

    • Hiroki Teragawa
    • Koichi Morita
    • Yasuki Kihara

    Original Article 14 November 2009 Pages: 368 - 376

    

20. Quantification of regional myocardial oxygen metabolism in normal pigs using positron emission tomography with injectable ¹⁵O-O₂

    • Takashi Temma
    • Hidehiro Iida
    • Yasuhiro Magata

    Original Article 04 September 2009 Pages: 377 - 385

    

21. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies

    • G. Malviya
    • F. Conti
    • A. Signore

    Review Article Open access 24 September 2009 Pages: 386 - 398

    

22. Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis

    • Giovanni Lucignani
    • Robert Perneczky

    Focus on 22 December 2009 Pages: 399 - 404

23. Bluth EI, Benson CB, Ralls PW, Siegel MJ (eds): Ultrasonography in vascular diseases. A practical approach to clinical problems (2nd edition)

    • Gianfranco Vallone
    • Massimo Vallone

    Book Review 31 October 2009 Pages: 405 - 406

24. PET/CT for the assessment and quantification of ⁹⁰Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases

    • Matthias K. Werner
    • Klaus Brechtel
    • Jürgen Kupferschläger

    Letter to the Editor 09 December 2009 Pages: 407 - 408

    

25. Unsuspected hibernating myocardium detected by routine oncology ¹⁸F-FDG PET/CT

    • Didier Vilain
    • Jean Bochet
    • Catherine Tainturier

    Image of the Month 09 December 2009 Pages: 409 - 409

26. Symmetrical nail bed uptake on a ^99mTc-HDP bone scan in a patient with Wegener’s granulomatosis

    • Danijela Dejanović
    • Alice Widding Høyer
    • Liselotte Højgaard

    Image of the Month 09 December 2009 Pages: 410 - 410

    

27. EANM’09 Barcelona–a congress to be remembered!

    Society Communications 30 January 2010 Pages: 411 - 419

28. Certificate of Fellowship of the European Board of Nuclear Medicine 2010 Information

    Society communications 22 December 2009 Pages: 420 - 429

29. Syllabus for postgraduate specialisation in Nuclear Medicine

    • Alberto Cuocolo
    • Metka Milčinski
    • Angelika Bischof Delaloye

    Society Communications 22 December 2009 Pages: 430 - 433

30. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2

    • Koen Van Laere
    • Andrea Varrone
    • Jacques Darcourt

    Guidelines 17 October 2009 Pages: 434 - 442

31. EANM procedure guidelines for brain neurotransmission SPECT using ¹²³I-labelled dopamine transporter ligands, version 2

    • Jacques Darcourt
    • Jan Booij
    • Koen Van Laere

    Guidelines 17 October 2009 Pages: 443 - 450